Hedgehog (Hh) signaling in Neurodegeneration represents a critical pathway at the intersection of neural development, adult brain homeostasis, and neurodegenerative disease pathogenesis. The Hedgehog pathway—comprising the ligands Sonic hedgehog (SHH), Indian hedgehog (IHH), and Desert hedgehog (DHH), along with their receptors PTCH1 and SMO, and GLI transcription factors—plays essential roles in embryonic development of the central nervous system and continues to function in the adult brain where it regulates neural stem cell proliferation, neuronal survival, synaptic plasticity, neuroinflammation, and glial cell function[1].
Dysregulation of Hedgehog signaling has been implicated in the pathogenesis of Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and other neurodegenerative disorders[2]. The pathway offers both diagnostic biomarkers and therapeutic targets, though significant challenges remain in translating preclinical findings to clinical applications.
The Hedgehog pathway in the adult brain maintains functions critical to neuronal health:
| Component | Role in Neurodegeneration | Expression in Disease |
|---|---|---|
| SHH | Primary neurotrophic factor | Reduced in AD/PD brains |
| IHH | Oligodendrocyte regulation | Altered in ALS |
| DHH | Testis-specific, minor brain role | Limited data |
| PTCH1 | Receptor, tumor suppressor | Upregulated reactively |
| SMO | Signal transducer | Therapeutic target |
| GLI1 | Transcription activator | Biomarker potential |
| GLI2 | Primary activator | Dysregulated |
| GLI3R | Transcriptional repressor | Reduced in disease |
Multiple studies document Hedgehog pathway alterations in Alzheimer's disease[3][4]:
SHH Expression Reduction: Significant downregulation of SHH mRNA and protein in hippocampal and cortical regions of AD brains, particularly in areas with high amyloid plaque burden.
GLI Transcription Factor Changes: GLI1 expression is altered in AD brain, correlating with Braak staging and clinical disease severity.
PTCH1 Receptor Alterations: Reactive changes in PTCH1 expression in microglia surrounding amyloid plaques.
SMO Signaling Dysfunction: Evidence of impaired SMO signaling in AD models.
The Hedgehog pathway intersects with multiple AD-related mechanisms:
Targeting Hedgehog signaling in Alzheimer's disease:
| Agent | Mechanism | Status | Notes |
|---|---|---|---|
| SAG | SMO agonist | Preclinical | Promotes neurogenesis |
| Purmorphamine | SMO agonist | Preclinical | Reduces Aβ pathology |
| Recombinant SHH | Ligand delivery | Preclinical | BBB penetration challenge |
| GANT61 | GLI inhibitor | Preclinical | Not suitable for AD |
The Hedgehog pathway is essential for the development and maintenance of dopaminergic neurons in the substantia nigra pars compacta[5]:
Postmortem studies and PD models reveal:
The Hedgehog pathway intersects with α-synuclein pathology[7]:
| Compound | Mechanism | Evidence Level | Notes |
|---|---|---|---|
| SAG | SMO agonist | Strong | Protects dopaminergic neurons |
| Purmorphamine | SMO agonist | Moderate | Oral bioavailability |
| GANT61 | GLI inhibitor | Moderate | Downstream targeting |
| Arsenic trioxide | GLI inhibitor | Clinical (cancer) | Potential repurposing |
Hedgehog signaling is crucial for motor neuron specification and survival[8]:
Evidence for Hedgehog pathway alterations in ALS:
| Approach | Agent | Stage | Target |
|---|---|---|---|
| SMO agonists | SAG | Preclinical | Enhance neuroprotection |
| SHH delivery | Recombinant SHH | Preclinical | Replace ligand |
| GLI targeting | GANT61 | Preclinical | Downstream effectors |
| Combination | SMO + growth factors | Preclinical | Multiple pathways |
Microglia express Hedgehog pathway components[9]:
Astrocyte Hedgehog signaling has important functions:
Modulating neuroinflammation through Hedgehog signaling:
The Hedgehog pathway regulates adult hippocampal neurogenesis[10][11]:
Dysregulated neurogenesis in AD and PD:
The Hedgehog pathway critically regulates oligodendrocyte biology[12]:
Astrocyte Hedgehog signaling:
Major challenge for Hedgehog-targeted therapeutics:
Oncogenic potential requires careful consideration:
The Hedgehog pathway intersects with multiple neurodegenerative disease mechanisms:
| Model | Applications | Limitations |
|---|---|---|
| SMO knockout mice | Pathway knockout studies | Embryonic lethal |
| Conditional knockout | Adult brain studies | Cell type specificity |
| SHH reporter mice | Pathway activity monitoring | Cost |
| iPSC neurons | Human disease modeling | Immature phenotype |
Hedgehog signaling represents a critical pathway in neurodegenerative diseases through its effects on neurogenesis, neuronal survival, synaptic function, neuroinflammation, and glial cell biology. While substantial evidence links Hedgehog pathway dysregulation to AD, PD, and ALS pathogenesis, significant challenges remain in translating these findings to clinical applications. Key priorities include developing brain-penetrant Hedgehog modulators with acceptable safety profiles, identifying biomarkers for patient selection and response monitoring, and understanding the optimal timing and cell-type-specificity of intervention. The pathway's importance in adult neural stem cells and its bidirectional relationship with neuroinflammation make it an attractive target for disease-modifying therapies in neurodegenerative disorders.
Ruiz i Altaba, A., et al. Hedgehog signaling in the neural tube. Cell. 2002. ↩︎
Katoh, Y. & Katoh, M. Hedgehog signaling in cancer. Nature Reviews Cancer. 2020. ↩︎
Peterson, S.M. & Beachler, D.C. Hedgehog signaling in Alzheimer's disease. Neurobiology of Disease. 2019. ↩︎
Marigliano, C., et al. Hedgehog modulation in Alzheimer's therapy. Journal of Alzheimer's Disease. 2019. ↩︎
Teng, L., et al. Sonic hedgehog promotes dopaminergic neuron survival. Molecular Neurobiology. 2017. ↩︎
Liao, J., et al. Smoothened agonists protect dopaminergic neurons. Journal of Parkinson's Disease. 2020. ↩︎
D, Y., et al. GLI1-mediated neuroprotection in Parkinson's disease models. Cell Death & Disease. 2018. ↩︎
Matsumoto, J., et al. Hedgehog pathway in ALS pathogenesis. Annals of Neurology. 2019. ↩︎
Sáenz, A. & Pizard, A. Hedgehog signaling and neuroinflammation. Glia. 2018. ↩︎
Huang, T., et al. Adult neurogenesis and Hedgehog signaling. Stem Cell Reports. 2020. ↩︎
Chen, K., et al. Sonic hedgehog in neurogenesis and cognition. Nature Communications. 2021. ↩︎
Palma, V., et al. Hedgehog in oligodendrocyte development. Developmental Biology. 2020. ↩︎